New targeted drugs could treat drug-resistant skin cancer
Existing drugs target faulty versions of a protein called BRAF which drives about half of all melanomas, but while initially very effective, the cancers almost always become resistant to treatment within a year. The new drugs — called panRAF inhibitors — could be effective in patients with melanoma who have developed resistance to BRAF inhibitors…